Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.37 |
| ▸ | LMNA | P02545 | 5/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | SLC13A5 | Q86YT5 | 7/20 | 0.35 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 1/20 | 0.35 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27580507 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL2394722 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL27588803 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL16680980 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL3880794 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL2178226 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL3079054 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNATSHRMAPT | |
| SCHEMBL27960985 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNATSHRMAPT | |
| Water SCHEMBL8752321 | 0.97 | ALDH1A1 (0.48) | ALDH1A1KDM4ELMNATSHRMAPT | |
| Hydrochloric Acid SCHEMBL1504745 | 0.95 | ALDH1A1 (0.47) | ALDH1A1KDM4ELMNATSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4030921-B1 | WHEY-BASED NUTRITIONAL COMPOSITIONS FORTIFIED WITH CALCIUM | NESTLE SA (CH) | 2024-02-21 | — | — | EP | claimed |
| CN-113264835-B | Lactoyl citrate plasticizer and preparation method thereof | 河南正通食品科技有限公司 | 2023-06-16 | — | — | CN | claimed |
| CN-106999313-A | Chemiluminescent wetness indicator for absorbent products | 国际纸业公司 | 2017-08-01 | — | — | CN | claimed |
| CN-104232503-B | Bacillus shacheensis and application thereof | 四川大学 | 2017-01-25 | — | — | CN | claimed |
| US-20160374352-A1 | BOTANICAL ANTIMICROBIAL COMPOSITIONS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2016-12-29 | — | — | US | claimed |
| CN-106139202-A | Biological deodorization preparation method of | 西安永成电子科技有限责任公司 | 2016-11-23 | — | — | CN | claimed |
| US-20160109776-A1 | Metal Sensitized Color Changing Material | UNIVERSITY OF SOUTH FLORIDA (US) | 2016-04-21 | — | — | US | claimed |
| CN-103726036-A | Environment-friendly high-brightness medium-phosphorus chemical nickel-plating additive | HARBIN SAN YONG GONG DA SCIENCE AND TECHNOLOGY CO LTD | 2014-04-16 | — | — | CN | claimed |
| US-20100324137-A1 | LAURIC ARGINATE AS A CONTACT ANTIMICROBIAL | DIVERSEY, INC. (US) | 2010-12-23 | — | — | US | claimed |
| CN-1958531-A | Nutrient solution of wood vinegar for edible fungus, and preparation method | YANG GUOTING (CN) | 2007-05-09 | — | — | CN | claimed |
| US-20060210480-A1 | Treatment of reduction of dysphagia | UNIVERSITY OF MANCHESTER, THE (GB) | 2006-09-21 | — | — | US | claimed |
| CN-1698617-A | Doxofylline freeze-dried powder injection for injection | DUAN YAJUN (CN) | 2005-11-23 | — | — | CN | claimed |
| EP-1198179-A1 | ANTIMICROBIAL POLYPHOSPHATES IN FOOD PROCESSING | ASTARIS LLC (US) | 2002-04-24 | — | — | EP | claimed |
| EP-1017770-A4 | AQUEOUS RINSING COMPOSITION | ARCH SPEC CHEM INC (US) | 2002-04-24 | — | — | EP | claimed |
| WO-2001006862-A1 | ANTIMICROBIAL POLYPHOSPHATES IN FOOD PROCESSING | ASTARIS LLC (US) | 2001-02-01 | — | — | WO | claimed |
| US-6123973-A | BY EXPOSING A SPECIFIED ANTIMICROBIAL PRODUCT SUCH AS SODIUM BENZOATE, OR POTASSIUM PROPIONATE CONTAINING A SMALL AMOUNT OF FREE ACIDS TO AMMONIA GAS TO OCNVERT THE FREE ACIDS INTO AMMONIOUM SALTS, MINIMIZING UNDESIRABLE FLAVORS OR ODORS | TILLIN, INC. (US) | 2000-09-26 | — | — | US | claimed |
| EP-1017770-A1 | AQUEOUS RINSING COMPOSITION | ARCH SPECIALTY CHEMICALS, INC. (US) | 2000-07-12 | — | — | EP | claimed |
| WO-1999015609-A1 | AQUEOUS RINSING COMPOSITION | ARCH SPECIALTY CHEMICALS, INC. (US) | 1999-04-01 | — | — | WO | claimed |
| US-5700452-A | CROSSLINKED CATIONIC POLYMER; QUATERNARY AMMONIUM SALT | THE PROCTER & GAMBLE COMPANY (US) | 1997-12-23 | — | — | US | claimed |
| CN-117481383-A | Aerosol generating matrix and method of making same | 谦逊恩典有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117441931-A | Aerosol-generating matrix precursors and methods of making the same | 谦逊恩典有限公司 | 2024-01-26 | — | — | CN | disclosed |
| US-20230263755-A1 | STABILIZATION OF ACETAMINOPHEN IN AQUEOUS SOLUTION | NOSTRUM PHARMACEUTICALS, LLC (US) | 2023-08-24 | — | — | US | disclosed |
| CN-113264835-B | Lactoyl citrate plasticizer and preparation method thereof | 河南正通食品科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| CN-113264835-B | Lactoyl citrate plasticizer and preparation method thereof | 河南正通食品科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| CN-113264835-B | Lactoyl citrate plasticizer and preparation method thereof | 河南正通食品科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| EP-3950645-A1 | SILICON-BASED AGRICULTURAL COMPOSITIONS | Biológicos Estratégicos Bioest S.A.S. (CO) | 2022-02-09 | — | — | EP | disclosed |
| EP-3393427-B1 | METHOD OF REDUCING PERSPIRATION | BEIERSDORF AG (DE) | 2021-09-08 | — | — | EP | disclosed |
| US-11079649-B2 | Metal sensitized color changing material | UNIVERSITY OF SOUTH FLORIDA (US) | 2021-08-03 | — | — | US | disclosed |
| US-20210227843-A1 | A TEMPERING COMPOSITION FOR TEMPERING GRAIN AND CONTROLLING PATHOGENS IN AND/OR ON SAID GRAIN, AN OXIDIZING COMPOSITION FOR PREPARING SAID TEMPERING COMPOSITION, A USE OF SAID TEMPERING COMPOSITION AND A METHOD OF USE OF SAID TEMPERING COMPOSITION | AGRI-NEO INC. (CA) | 2021-07-29 | — | — | US | disclosed |
| CN-107526945-B | Method for evaluating cow milk components and feed conversion level by serum NEFA | 黑龙江八一农垦大学 | 2021-01-29 | — | — | CN | disclosed |
| EP-3697226-A1 | A TEMPERING COMPOSITION FOR TEMPERING GRAIN AND CONTROLLING PATHOGENS IN AND/OR ON SAID GRAIN, AN OXIDIZING COMPOSITION FOR PREPARING SAID TEMPERING COMPOSITION, A USE OF SAID TEMPERING COMPOSITION AND A METHOD OF USE OF SAID TEMPERING COMPOSITION | Agri-Néo Inc. (CA) | 2020-08-26 | — | — | EP | disclosed |
| CN-105461693-B | CRTH2 agonist compounds and application thereof | 广东东阳光药业有限公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-110358080-A | A kind of epimedium aglucone derivative and its preparation method and application | 鲁南制药集团股份有限公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-110358074-A | Epimedium aglucone derivative and its preparation method and application | 鲁南制药集团股份有限公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-110358075-A | Epimedium aglucone derivative and its preparation method and application | 鲁南制药集团股份有限公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-110358079-A | Epimedium aglucone derivative and its preparation method and application | 鲁南制药集团股份有限公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-110358078-A | Epimedium aglucone derivative and its preparation method and application | 鲁南制药集团股份有限公司 | 2019-10-22 | — | — | CN | disclosed |
| WO-2019075565-A1 | A TEMPERING COMPOSITION FOR TEMPERING GRAIN AND CONTROLLING PATHOGENS IN AND/OR ON SAID GRAIN, AN OXIDIZING COMPOSITION FOR PREPARING SAID TEMPERING COMPOSITION, A USE OF SAID TEMPERING COMPOSITION AND A METHOD OF USE OF SAID TEMPERING COMPOSITION | AGRI-NEO INC. (CA) | 2019-04-25 | — | — | WO | disclosed |
| CN-109641395-A | The manufacturing method of ink-jet 3D printer photo-curable backing material composition, ink-jet 3D printer ink, ink-jet 3D printer print cartridge, the manufacturing method of backing material and light chisel object | 株式会社日本触媒 | 2019-04-16 | — | — | CN | disclosed |
| CN-105294655-B | The compound and application thereof of CDK type small molecular inhibitor | 广东东阳光药业有限公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-104926808-B | Dihydropyrimidines and its application in drug | 广东东阳光药业有限公司 | 2018-09-14 | — | — | CN | disclosed |
| CN-105272930-B | Substituted urea derivative and its application in drug | 广东东阳光药业有限公司 | 2018-07-13 | — | — | CN | disclosed |
| CN-107922315-A | CATHEPSIN K INHIBITOR AND APPLICATION THEREOF | 广东东阳光药业有限公司 | 2018-04-17 | — | — | CN | disclosed |
| CN-105764900-B | CRTH2 agonist compounds and application thereof | 广东东阳光药业有限公司 | 2018-04-03 | — | — | CN | disclosed |
| CN-104513258-B | Substituted urea derivative and its application in medicine | 广东东阳光药业有限公司 | 2018-04-03 | — | — | CN | disclosed |
| CN-103664897-B | Dihydropyrimidines and its application in medicine | 广东东阳光药业有限公司 | 2018-04-03 | — | — | CN | disclosed |
| CN-105294683-B | Compound of CDK type small molecular inhibitors and application thereof | 广东东阳光药业有限公司 | 2018-01-23 | — | — | CN | disclosed |
| CN-103664925-B | The Dihydropyrimidines of heteroaryl substitution and its application in medicine | 广东东阳光药业有限公司 | 2018-01-23 | — | — | CN | disclosed |
| EP-3257514-A1 | ANTIDIABETIC EFFECT OF GYPENOSIDE 75 | Intelligent Synthetic Biology Center (KR) | 2017-12-20 | — | — | EP | disclosed |
| CN-104513252-B | Substituted urea derivative and its application in medicine | 广东东阳光药业有限公司 | 2017-11-10 | — | — | CN | disclosed |
| CN-104447730-B | Oxazolidinone compounds and its application in medicine | 广东东阳光药业有限公司 | 2017-11-07 | — | — | CN | disclosed |
| CN-106999313-A | Chemiluminescent wetness indicator for absorbent products | 国际纸业公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-105294682-B | Compound of CDK type small molecular inhibitors and application thereof | 广东东阳光药业有限公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-105294681-B | Compound of CDK type small molecular inhibitors and application thereof | 广东东阳光药业有限公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-104478866-B | Oxazolidinone compounds and its application in medicine | 广东东阳光药业有限公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-103664899-B | The Dihydropyrimidines of heteroaryl substitution and its application in medicine | 广东东阳光药业有限公司 | 2017-06-16 | — | — | CN | disclosed |
| CN-104513259-B | Substituted urea derivative and its application in medicine | 广东东阳光药业有限公司 | 2017-06-16 | — | — | CN | disclosed |
| CN-104478869-B | Oxazolidinone compound and application thereof to drugs | 广东东阳光药业有限公司 | 2017-04-12 | — | — | CN | disclosed |
| CN-104513257-B | Substituted urea derivatives and application thereof in drugs | 广东东阳光药业有限公司 | 2017-02-15 | — | — | CN | disclosed |
| CN-104232503-B | Bacillus shacheensis and application thereof | 四川大学 | 2017-01-25 | — | — | CN | disclosed |
| CN-104529974-B | Barrenwort glycosides compounds and application thereof | 广东东阳光药业有限公司 | 2017-01-04 | — | — | CN | disclosed |
| CN-104447728-B | Oxazolidinones and the application in medicine thereof | 广东东阳光药业有限公司 | 2017-01-04 | — | — | CN | disclosed |
| CN-106139202-A | Biological deodorization preparation method of | 西安永成电子科技有限责任公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-106148920-A | The invention claims a rare earth permanent magnet acidity chemical nickel plating working liquid | 修建东 | 2016-11-23 | — | — | CN | disclosed |
| CN-106139202-A | Biological deodorization preparation method of | 西安永成电子科技有限责任公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-104402833-B | Pyrazine compounds containing cyclobutane substituent and combinations thereof thing and purposes | 广东东阳光药业有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104447583-B | Pyrazine compounds containing cyclobutane substituent and combinations thereof thing and purposes | 广东东阳光药业有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104447585-B | Pyrazine compounds and combinations thereof thing and purposes | 广东东阳光药业有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-104447584-B | Pyrazine compounds containing cyclobutane substituent and combinations thereof thing and purposes | 广东东阳光药业有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-105764900-A | Compounds as CRTH2 antagonist and uses thereof | 广东东阳光药业有限公司 | 2016-07-13 | — | — | CN | disclosed |
| US-20160109776-A1 | Metal Sensitized Color Changing Material | UNIVERSITY OF SOUTH FLORIDA (US) | 2016-04-21 | — | — | US | disclosed |
| CN-105461693-A | Crth2 antagonist compound and use thereof | GUANGDONG HEC PHARMACEUTICAL | 2016-04-06 | — | — | CN | disclosed |
| CN-105461709-A | Substituted carbamide derivative and applications thereof in drugs | GUANGDONG HEC PHARMACEUTICAL | 2016-04-06 | — | — | CN | disclosed |
| CN-105294681-A | CDK small-molecule inhibitor compounds and application therefore | GUANGDONG HEC PHARMACEUTICAL | 2016-02-03 | — | — | CN | disclosed |
| CN-105294655-A | CDK small-molecule inhibitor compounds and application therefore | GUANGDONG HEC PHARMACEUTICAL | 2016-02-03 | — | — | CN | disclosed |
| CN-105294682-A | CDK small-molecule inhibitor compounds and application therefore | GUANGDONG HEC PHARMACEUTICAL | 2016-02-03 | — | — | CN | disclosed |
| CN-105294683-A | CDK small-molecule inhibitor compounds and application thereof | GUANGDONG HEC PHARMACEUTICAL | 2016-02-03 | — | — | CN | disclosed |
| CN-105272930-A | Substituted urea derivatives and uses thereof in pharmaceuticals | GUANGDONG HEC PHARMACEUTICAL | 2016-01-27 | — | — | CN | disclosed |
| CN-104926808-A | Dihydro-pyrimidine compound and application thereof in medicine | GUANGDONG HEC PHARMACEUTICAL | 2015-09-23 | — | — | CN | disclosed |
| CN-103626752-B | Dihydropyrimidine compound and application thereof in medicine | SUNSHINE LAKE PHARMA CO.,LTD. (CN) | 2015-08-12 | — | — | CN | disclosed |
| CN-104529974-A | Icariin compound and application thereof | GUANGDONG HEC PHARMACEUTICAL | 2015-04-22 | — | — | CN | disclosed |
| CN-104513257-A | Substituted urea derivatives and application thereof in drugs | GUANGDONG HEC PHARMACEUTICAL | 2015-04-15 | — | — | CN | disclosed |
| CN-104513259-A | Substituted urea derivatives and application thereof in drugs | GUANGDONG HEC PHARMACEUTICAL | 2015-04-15 | — | — | CN | disclosed |
| CN-104513252-A | Substituted urea derivatives and application thereof in drugs | GUANGDONG HEC PHARMACEUTICAL | 2015-04-15 | — | — | CN | disclosed |
| CN-104513258-A | Substituted urea derivatives and application thereof in drugs | GUANGDONG HEC PHARMACEUTICAL | 2015-04-15 | — | — | CN | disclosed |
| CN-104478866-A | Oxazolidinone compound and application thereof to drugs | GUANGDONG HEC PHARMACEUTICAL | 2015-04-01 | — | — | CN | disclosed |
| CN-104478869-A | Oxazolidinone compound and application thereof to drugs | GUANGDONG HEC PHARMACEUTICAL | 2015-04-01 | — | — | CN | disclosed |
| CN-104447583-A | Cyclobutane substituent group-containing pyrazine compound and composition and application thereof | GUANGDONG HEC PHARMACEUTICAL | 2015-03-25 | — | — | CN | disclosed |
| CN-104447730-A | Oxazolidinone compounds and application thereof to drugs | GUANGDONG HEC PHARMACEUTICAL | 2015-03-25 | — | — | CN | disclosed |
| CN-104447584-A | Cyclobutane substituent containing pyrazine compound, and composition and use thereof | GUANGDONG HEC PHARMACEUTICAL | 2015-03-25 | — | — | CN | disclosed |
| CN-104447728-A | Oxazolidinone compounds and application thereof to drugs | GUANGDONG HEC PHARMACEUTICAL | 2015-03-25 | — | — | CN | disclosed |
| CN-104447585-A | Pyrazine compound and composition and application thereof | GUANGDONG HEC PHARMACEUTICAL | 2015-03-25 | — | — | CN | disclosed |
| CN-104447729-A | Oxazolidinone compound and application thereof in medicines | GUANGDONG HEC PHARMACEUTICAL | 2015-03-25 | — | — | CN | disclosed |
| CN-104402833-A | Pyrazine compound containing diethylene substituent and composition and application thereof | GUANGDONG HEC PHARMACEUTICAL | 2015-03-11 | — | — | CN | disclosed |
| CN-103664925-A | Heteroaryl-substituted dihydropyrimidine compounds and application thereof in medicines | GUANGDONG HEC PHARMACEUTICAL | 2014-03-26 | — | — | CN | disclosed |
| CN-103664897-A | Dihydropyrimidine compounds and application thereof in medicines | GUANGDONG HEC PHARMACEUTICAL | 2014-03-26 | — | — | CN | disclosed |
| CN-103626752-A | Dihydropyrimidine compound and application thereof in medicine | GUANGDONG HEC PHARMACEUTICAL | 2014-03-12 | — | — | CN | disclosed |
| CN-103443196-A | Aqueous fluoropolymer dispersion | DAIKIN IND LTD | 2013-12-11 | — | — | CN | disclosed |
| CN-102100710-B | Fermentation processing method for ginseng and research and development of related products thereof | WANG ZENGGANG | 2013-05-01 | — | — | CN | disclosed |
| EP-2288265-B1 | SODIUM-POTASSIUM HEXAMETAPHOSPHATE AND POTASSIUM METAPHOSPHATE WITH A LOW INSOLUBLES CONTENT | ICL PERFORMANCE PRODUCTS LP (US) | 2013-04-24 | — | — | EP | disclosed |
| US-20130004542-A1 | COMPOSITION | INNOVATA LIMITED (GB) | 2013-01-03 | — | — | US | disclosed |
| CN-102665684-A | Composition for inhalation | INNOVATA LTD | 2012-09-12 | — | — | CN | disclosed |
| EP-2490670-A2 | COMPOSITION FOR INHALATION | Innovata Limited (GB) | 2012-08-29 | — | — | EP | disclosed |
| WO-2012076911-A2 | LOW CARBOHYDRATE FLOURS FOR THE FOOD INDUSTRY AND USE THEREOF IN SEMI-FINISHED AND FINAL FOOD PRODUCTS | BAKONYI-KISS ATTILA (HU) | 2012-06-14 | — | — | WO | disclosed |
| CN-101467558-B | Active lactic acid bacteria beverage and method for producing the same | YILI IND CO., LTD., INNER MONGOLIA (CN) | 2011-12-14 | — | — | CN | disclosed |
| US-8067321-B2 | Sodium-potassium hexametaphosphate and potassium metaphosphate with a low insolubles content | ICL PERFORMANCE PRODUCTS, LP (US) | 2011-11-29 | — | — | US | disclosed |
| CN-102100710-A | Fermentation processing method for ginseng and research and development of related products thereof | HAIYING BAO | 2011-06-22 | — | — | CN | disclosed |
| WO-2011048379-A2 | COMPOSITION | INNOVATA LIMITED (GB) | 2011-04-28 | — | — | WO | disclosed |
| EP-2288265-A2 | SODIUM-POTASSIUM HEXAMETAPHOSPHATE AND POTASSIUM METAPHOSPHATE WITH A LOW INSOLUBLES CONTENT | ICL Performance Products LP (US) | 2011-03-02 | — | — | EP | disclosed |
| CN-101792382-A | Method for preparing disinfected-decolorized fish-squamosum organic acid calcium and non-denatured collagen | YAN SONG | 2010-08-04 | — | — | CN | disclosed |
| WO-2009154912-A2 | SODIUM-POTASSIUM HEXAMETAPHOSPHATE AND POTASSIUM METAPHOSPHATE WITH A LOW INSOLUBLES CONTENT | ICL PERFORMANCE PRODUCTS LP (US) | 2009-12-23 | — | — | WO | disclosed |
| US-20090291821-A1 | Sodium-Potassium Hexametaphosphate and Potassium Metaphosphate with a Low Insolubles Content | ICL PERFORMANCE PRODUCTS LP (US) | 2009-11-26 | — | — | US | disclosed |
| EP-1977248-A4 | HUMAN ZIP1, ZINC AND CITRATE FOR PROSTATE CANCER SCREENING | UNIV MARYLAND (US) | 2009-08-05 | — | — | EP | disclosed |
| CN-101467558-A | Active lactic acid bacteria beverage and method for producing the same | SICHUAN MEIDI PHARMACEUTICAL C (CN) | 2009-07-01 | — | — | CN | disclosed |
| US-7534293-B2 | Method and solution for forming anatase titanium dioxide, and titanium dioxide particles, colloidal dispersion and film | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-05-19 | — | — | US | disclosed |
| EP-1977248-A2 | HUMAN ZIP1, ZINC AND CITRATE FOR PROSTATE CANCER SCREENING | THE UNIVERSITY OF MARYLAND AT BALTIMORE (US) | 2008-10-08 | — | — | EP | disclosed |
| EP-1895970-A1 | IMPROVEMENTS IN SKIN AND HAIR CARE | Quest International Services B.V. (NL) | 2008-03-12 | — | — | EP | disclosed |
| CN-101029316-A | Production of succinate from colon bacillus | HUADONG SCIENCE & ENGINEERING (CN) | 2007-09-05 | — | — | CN | disclosed |
| US-7259173-B2 | Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions | NOVARTIS AG (CH) | 2007-08-21 | — | — | US | disclosed |
| WO-2007087263-A2 | HUMAN ZIP1, ZINC AND CITRATE FOR PROSTATE CANCER SCREENING | THE UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2007-08-02 | — | — | WO | disclosed |
| EP-1198179-B1 | ANTIMICROBIAL POLYPHOSPHATES IN FOOD PROCESSING | ASTARIS LLC (US) | 2007-01-17 | — | — | EP | disclosed |
| WO-2007000586-A1 | IMPROVEMENTS IN SKIN AND HAIR CARE | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2007-01-04 | — | — | WO | disclosed |
| US-20060254461-A1 | METHOD AND SOLUTION FOR FORMING ANATASE TITANIUM DIOXIDE, AND TITANIUM DIOXIDE PARTICLES, COLLOIDAL DISPERSION AND FILM | AGENCY FOR SCIENCE, TECHNOLOGY, AND RESEARCH (SG) | 2006-11-16 | — | — | US | disclosed |
| EP-1721867-A2 | Method and solution for forming anatase titanium dioxide, and titanium dioxide particules, colloidal dipersion and film | Agency for Science, Technology and Research (SG) | 2006-11-15 | — | — | EP | disclosed |
| EP-1332202-B1 | COMPOSITIONS AND METHODS FOR MITIGATING CORROSION OF APPLIED COLOR DESIGNS | ECOLAB INC (US) | 2006-10-18 | — | — | EP | disclosed |
| EP-1401814-B1 | DERIVATIVES OF 3-PHENYL-N-(2- (4-BENZYL) PIPERIDIN-1-YL)-ETHYL)-ACRYLAMID WITH CCR-3 RECEPTOR ANTAGONISTIC ACTIVITY FOR USE IN THE TREATMENT OF INFLAMMATIONS AND ALLERGIC CONDITIONS | NOVARTIS AG (CH) | 2006-09-06 | — | — | EP | disclosed |
| US-20050215562-A1 | Methods for treating protein aggregation disorders | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-09-29 | — | — | US | disclosed |
| US-20040180926-A1 | Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions | NOVARTIS AG (CH) | 2004-09-16 | — | — | US | disclosed |
| EP-1401814-A1 | DERIVATIVES OF 3-PHENYL-N-(2- (4-BENZYL) PIPERIDIN-1-YL)-ETHYL)-ACRYLAMID WITH CCR-3 RECEPTOR ANTAGONISTIC ACTIVITY FOR USE IN THE TREATMENT OF INFLAMMATIONS AND ALLERGIC CONDITIONS | Novartis AG (CH) | 2004-03-31 | — | — | EP | disclosed |
| US-6562874-B1 | Composition may be prepared in a single DEFI reactor comprising mixtures of (1) DEFI (directly esterified fatty acyl isethionate) and (2) a compound produced by the reaction of (a) isethionate with a fatty acid replacement | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. | 2003-05-13 | — | — | US | disclosed |
| US-6509050-B1 | Preventing growth of listeria monocytogenes, pseudonomas aeruginosa and escherichia coli in meat, poultry and seafood; washing with aqueous solution containing sodium and/or potassium polyphosphate and polycarboxylic acid | ASTARIS LLC | 2003-01-21 | — | — | US | disclosed |
| WO-2002102775-A1 | DERIVATIVES OF 3-PHENYL-N-(2- (4-BENZYL) PIPERIDIN-1-YL)-ETHYL)-ACRYLAMID WITH CCR-3 RECEPTOR ANTAGONISTIC ACTIVITY FOR USE IN THE TREATMENT OF INFLAMMATIONS AND ALLERGIC CONDITIONS | NOVARTIS AG (CH) | 2002-12-27 | — | — | WO | disclosed |
| EP-0844006-B1 | Liquid-absorbing material composition, molded product therefrom, process for preparing the same and use thereof | SHOWA DENKO KK (JP) | 2002-06-05 | — | — | EP | disclosed |
| CN-1352528-A | Milk protein hydrolysate for addressing a bone or dental disorder | NESTLE SA (CH) | 2002-06-05 | — | — | CN | disclosed |
| EP-1198179-A1 | ANTIMICROBIAL POLYPHOSPHATES IN FOOD PROCESSING | ASTARIS LLC (US) | 2002-04-24 | — | — | EP | disclosed |
| WO-2001006862-A1 | ANTIMICROBIAL POLYPHOSPHATES IN FOOD PROCESSING | ASTARIS LLC (US) | 2001-02-01 | — | — | WO | disclosed |
| US-6051213-A | Detergent cosmetic compositions for hair use and use thereof | L'OREAL (FR) | 2000-04-18 | — | — | US | disclosed |
| US-5965651-A | CONTAINING A CROSSLINKING AGENT, N-VINYLCARBOXAMIDE COPOLYMER HAVING A FUNCTIONAL GROUP CAPABLE OF CROSSLINKING WITH CROSSLINKER, WATER, WATER SOLUBLE ORGANIC SOLVENT, AND PLASTICIZER; MOLDED INTO FILMS, SHEETS, POWDER AND FLAKES | SHOWA DENKO K.K. (JP) | 1999-10-12 | — | — | US | disclosed |
| US-5858341-A | MIXTURE CONTAINING SULFATE SALT ANIONIC SURFACTANT, ALKYL POLYGLYCOSIDE NONIONIC SURFACTANT, CATIONINC POLYMER CONDITIONING AGENT AND AT LEAST ONE OF CITRIC ACID, LACTIC ACID AND TARTARTIC ACID | L'OREAL (FR) | 1999-01-12 | — | — | US | disclosed |
| EP-0844006-A1 | Liquid-absorbing material composition, molded product therefrom, process for preparing the same and use thereof | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1998-05-27 | — | — | EP | disclosed |
| EP-0443030-B1 | SOLDERING FLUX | DENSO CORP (JP) | 1997-06-11 | — | — | EP | disclosed |
| US-5534586-A | Grinding and/or dispersing agent containing polymers and/or copolymers partially neutralized by magnesium for aqueous suspensions of mineral substances, to be used in pigmentary applications | COATEX S.A. (FR) | 1996-07-09 | — | — | US | disclosed |
| US-5167729-A | Suitable for automobiles; nonpolluting; corrosion resistance | NIPPONDENSO CO., LTD. (JP) | 1992-12-01 | — | — | US | disclosed |
| EP-0443030-A1 | SOLDERING FLUX | NIPPONDENSO CO., LTD. (JP) | 1991-08-28 | — | — | EP | disclosed |
| CN-85106500-A | Preparation 1, the method for 6-naphthyridines derivatives and medicinal group and thing | — | 1986-07-23 | — | — | CN | disclosed |
| EP-0083477-B1 | A METHOD OF MANUFACTURING A FOUNDRY MOULD MIX CONTAINING BINDER COMPONENTS AND MOULD BINDER COMPONENTS THEREFOR | Canadian Patents and Development Limited (CA) | 1986-06-04 | — | — | EP | disclosed |
| EP-0083477-A1 | A method of manufacturing a foundry mould mix containing binder components and mould binder components therefor | Canadian Patents and Development Limited (CA) | 1983-07-13 | — | — | EP | disclosed |
| US-3985691-A | FOR THE MANUFACTURE OF POLYURETHANE LACQUERS | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1976-10-12 | — | — | US | disclosed |
| US-3985691-A | FOR THE MANUFACTURE OF POLYURETHANE LACQUERS | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215562-A1 | Methods for treating protein aggregation disorders | HTT, HSPBP1, PRNP | ALDH1A1 4068/4885KDM4E 4531/4885LMNA 1213/4885 |
| US-20040180926-A1 | Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions | CCR1, CCR3, CCR4 | ALDH1A1 629/4885KDM4E 3230/4885LMNA 3565/4885 |
| US-20130004542-A1 | COMPOSITION | MATR3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, IL5 | ALDH1A1 4362/4885KDM4E 2933/4885LMNA 819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.